Why a dead-clean sterile filter can pass pyrogen straight through
Bacterial endotoxin is a heat-stable lipopolysaccharide from the outer membrane of Gram-negative organisms. It survives sterilisation, passes a sterilising filter, and is…
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Analytics
Nothing on this page is difficult. It is simply unfamiliar, and unfamiliarity is what makes a weak certificate look like a strong one.
A certificate of analysis is not a test result. It is a statement, made by whoever signs it, that a defined quantity of material identified by a batch number was subjected to defined tests by defined methods and produced results within defined limits on a defined date. Every element of that sentence is load-bearing, and a document missing any of them is not a weak certificate but a different kind of object: an assertion of quality with no way back to the evidence. The Journal has read several hundred of these and the distribution is not encouraging, though the reason is more mundane than the trade’s more excitable commentary suggests.
The confusion at the root of almost every dispute about certificates is a category error. A certificate of analysis is not a measurement. It is a record asserting that measurements were made, by named methods, on identified material, on a stated date, with stated outcomes, and that somebody reviewed and released the batch on that basis. The measurements exist elsewhere: in instrument data files, in analyst notebooks, in a laboratory information system. The certificate is the summary that travels with the goods.
This distinction has a practical consequence. When the Journal wants to know whether a purity figure is sound, we do not scrutinise the certificate; we ask for the underlying laboratory report and, where possible, the chromatogram. The certificate can only tell us what somebody concluded. The chromatogram tells us what the instrument saw, and the two are separated by decisions about integration, thresholds and reporting that the certificate does not record.
It follows that a certificate’s value is almost entirely a function of whether it can be traced back to that underlying evidence. A document with a batch number, a date, a named method and a named analyst is checkable in principle even if nobody ever checks it. A document with a percentage and a logo is not checkable by anyone, including the company that issued it, and the difference between those two situations is invisible to a buyer who reads only the number.
The top of a certificate answers the question, what is this document about. A complete header names the product, gives a catalogue or item number, gives the batch or lot number, states the quantity or fill weight, names the manufacturer and the site, and identifies the customer or order where applicable. Some add a chemical name, a sequence in single-letter code, a molecular formula and a molecular weight, all of which are useful because they let a reader check the theoretical values used elsewhere on the page.
The sequence in particular is worth insisting on. A certificate that prints the one-letter sequence has given a reader the means to calculate the expected mass independently, and therefore to check the identity line. Two of the twenty companies in the Journal’s dossier programme do this as standard. It costs nothing and it converts one line of the document from an assertion into a verifiable claim.
What a header should never do is identify the product only by a trade name. A vial described as a proprietary blend with no chemical identity, no formula and no sequence cannot be checked against anything, and a certificate for such a product is a document about a name. This is a documentary observation rather than an accusation, and the remedy is trivial: print the sequence.
A purity limit of ≥95% on material that always reports 99% is not a control. It is a formality with a number attached.
On decorative acceptance criteriaThe body of a certificate is a table, and a complete one has four columns: the test performed, the method used, the specification applied, and the result obtained. Four columns, one row per test. That structure is not a convention peculiar to pharmaceuticals; it is what a record of controlled testing looks like in any field, because each column answers a question the other three cannot.
The method column is where the detail belongs — not the word HPLC but a method identifier, a gradient, a wavelength, a column chemistry. The specification column states what the batch had to achieve. The result column states what it did. A certificate carrying only test and result has dropped the two columns that make the result interpretable, and this is by far the commonest structural deficiency the Journal encounters.
The compendial framework for validating an analytical procedure exists precisely to establish that a stated method can discriminate what it claims to discriminate, which is why a method reference is not bureaucratic ornament but the hook on which everything else hangs.12 A named method can be looked up, compared, criticised and repeated. An unnamed one cannot be, and a result generated by one is a number whose provenance stops at the page.
| Finding | Certificates | Resolved on enquiry | Unresolved |
|---|---|---|---|
| Batch number absent from the vial itself | 19 | 14 | 5 |
| No specification column for one or more tests | 17 | 11 | 6 |
| Method stated only as an acronym | 16 | 9 | 7 |
| Date of manufacture absent | 13 | 10 | 3 |
| No name in the signature block | 11 | 7 | 4 |
| Expiry date with no supporting stability data | 9 | 6 | 3 |
| Molecular weight inconsistent with printed sequence | 3 | 3 | 0 |
| Chromatogram identical to one on another document | 2 | 1 | 1 |
| Sixty-three certificates supplied to the Journal between the first quarter of 2025 and the second quarter of 2026, covering the twenty companies in the dossier programme and eleven others. “Resolved on enquiry” means the company supplied an explanation or corrected document that the standards desk accepted. No finding in this table is presented as evidence of misconduct by any company. | |||
Near the top of most test tables sit two entries that buyers skip and chemists do not: appearance and solubility. Appearance is reported as something like “white to off-white lyophilised powder”, and it is a real test with real discriminating power. A peptide cake that is yellow, or grey, or that has collapsed into a glassy plug rather than a light lyophilised mass, is telling you something about the drying cycle, about oxidation, or about a temperature excursion in transit.
Solubility is similarly underrated. A specification reading “clear, colourless solution on reconstitution in water at 1 mg/mL” establishes that the material dissolves at the concentration a user will need, without haze, and haze on reconstitution is a genuine finding: it can indicate aggregation, incomplete removal of a protecting group, or particulate contamination. It is also the only test on most certificates that a buyer can repeat at home.
The reason to press on these lines is that they are cheap, they are already on the form, and they degrade in a way the purity figure does not capture. A certificate reporting a white powder for material that arrives faintly yellow has not been falsified. It has been overtaken by events, which is exactly what a certificate with an eleven-month-old date of analysis should be expected to be.
A lyophilised peptide is not pure peptide even when it is chromatographically pure. It is a salt, usually of trifluoroacetic or acetic acid, containing residual water that a hygroscopic powder acquires readily, and sometimes residual solvent from purification. Three lines on a certificate address this and they are usually absent: water content, counter-ion identity and content, and residual solvent.
Water is determined by Karl Fischer titration or by loss on drying, and the pharmacopoeial methods for it are old, settled and inexpensive.3 A peptide containing eight per cent water by mass contains eight per cent less peptide than its label implies, and the figure is not stable: it depends on how the vial was stoppered and how long it has been open. Counter-ion content is a larger contribution still for basic peptides purified in trifluoroacetic acid, where the counter-ion fraction can reach ten to twenty per cent of total mass.4
Put these together and the practical statement is the one this department repeats: the nominal mass on a research vial is an upper bound on the peptide it contains, not a value. A certificate that reports purity and is silent on water and counter-ion has told you the material is clean and nothing at all about how much of it there is.
The bottom of a certificate carries the dates, the signatures and any boilerplate. A complete footer gives the date of manufacture, the date of analysis, and either a retest date or an expiry date with the convention named. It gives the name and role of the person who performed or compiled the testing, and separately of the person who reviewed and approved it. It states the storage conditions under which the stated properties hold. And it states, in a research-chemical context, the research-use-only restriction.
The two-signature convention is worth explaining because its absence is so universal here that its purpose is forgotten. Separating performance from approval is a control against a single person’s error or judgement determining a release. It is cheap, it requires no equipment, and it is the ordinary practice in every regulated laboratory. Its function is not ceremonial: it means that when a document turns out to be wrong, there is a record of who reviewed it and on what basis.
What the footer should not carry is a signature rendered as a reused image with no accompanying name. That is not evidence of anything improper on its own — scanned signature blocks are common in legitimate commerce — but it removes the one piece of information the block exists to supply, which is the identity of a person who can be asked.
Readers who take one habit from this piece should take the first minute of the ten-minute check. Find the batch number on the vial. Everything else on the document is a claim about a defined quantity of material, and if the vial is not identifiably part of that quantity then the rest of the page is a well-drafted statement about something else.
Selected from correspondence received on this article. Writers are identified by initial, surname and city, verified before printing. Replies are from the desk that filed the piece or from the standards editor. Write to letters@compoundjournal.com.
I have a certificate with an expiry date twenty-four months from manufacture and no stability data behind it, which your article says is a claim the documentation cannot support. The supplier tells me it is industry standard. Is it?
— D. Ramkissoon, Port of Spain
Twenty-four months is a common default and “industry standard” is an accurate description of the practice rather than a justification of the claim. The distinction we would press is between an expiry date, which asserts shelf life, and a retest date, which asserts only a review interval. The second is defensible without stability data. The first is not.
On the accreditation-scope point: most private buyers will not know which accreditation body to search. It would be more useful to publish the four or five registers that cover the laboratories this market actually uses than to tell readers the registers exist.
— P. Kovalenko, Lviv
Agreed, and the standards desk is compiling exactly that. It will appear as a standing reference page rather than inside an article, so that it can be kept current.
The composite test table you print as a model is unrealistic. No research supplier is going to run headspace GC and ion chromatography on every lot at these price points, and publishing an aspirational document as a benchmark just makes real certificates look worse than they are.
— C. Adeoti, Ibadan
The table note says explicitly that no supplier in our programme issues a document containing every row, and it is offered as a reference rather than as a demand. But you have a point about framing, and we have moved the caveat from the note into the caption.
Nine years buying research chemicals and I had never once looked at the date of manufacture. I checked eleven certificates in my drawer this evening. Four do not carry one.
— R. Anand, Pune
I supply research peptides and I want to push back on the specification column point. We sell from a catalogue of six hundred products. Writing a meaningful individual specification for each would take a year of somebody’s time, and a generic one would be exactly the decorative limit your article criticises. What would you actually have us do?
— D. Mazzarella, Catania
A fair challenge. Our answer is that a generic limit stated honestly is better than no limit at all, provided the typical result is also published so a reader can see the margin. What we object to is a decorative limit presented as a control. Publishing your process capability alongside it removes the objection entirely, and costs you a spreadsheet.
Bacterial endotoxin is a heat-stable lipopolysaccharide from the outer membrane of Gram-negative organisms. It survives sterilisation, passes a sterilising filter, and is…
A result on one vial generalises to a batch only if the vial was drawn in a way that makes it representative — and nobody records how it was drawn.
Lot-level verification with a public report is a real and achievable thing. It exists in this market, on a minority of listings.
Every step between the laboratory report and the product page removes information, and the badge is the last step.
The mechanism is well described. The variance is not.
A blank certificate with the numbers left editable is an ordinary internal document. Its circulation as a finished record is the problem.